Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions include bone graft substitutes (BGS) that increase bone formation to stimulate bone healing in spinal fusions and other orthopedic surgeries, as well as a portfolio of ultrasonic products used for precise bone cutting and sculpting, soft tissue management and tissue debridement in various surgeries. Its Restorative Therapies comprise a bone stimulation system, as well as devices designed to help patients regain leg or hand function due to stroke, multiple sclerosis or other central nervous system disorders.
Código da empresaBVS
Nome da EmpresaBioventus Inc
Data de listagemFeb 11, 2021
CEOMr. Robert E. Claypoole
Número de funcionários930
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 11
Endereço4721 Emperor Boulevard, Suite 100
CidadeDURHAM
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal27703
Telefone19194746700
Sitehttps://www.bioventus.com/
Código da empresaBVS
Data de listagemFeb 11, 2021
CEOMr. Robert E. Claypoole
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.

Sem dados